---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-026051"
form_type: "8-K"
ticker: "PVLA"
cik: "0001583648"
company_name: "PALVELLA THERAPEUTICS, INC."
filed_at: "2022-11-04T23:59:59+00:00"
generated_at: "2026-06-22T06:56:14.163829+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pieris Pharmaceuticals increases ATM offering capacity to $75M under amended Jefferies agreement

## Summary
- As of Nov 4, 2022, Pieris had sold $33.6M of stock under the prior $50M ATM program.
- Amendment raises aggregate offering amount to $75M, exclusive of shares previously sold.
- Jefferies will use commercially reasonable efforts for at-the-market sales on Nasdaq.
- Company is not obligated to sell any shares; other terms of the Sales Agreement unchanged.

## SEC filing metadata
- accession: 0001437749-22-026051
- form_type: 8-K
- ticker: PVLA
- cik: 0001583648
- company_name: PALVELLA THERAPEUTICS, INC.
- filed_at: 2022-11-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583648/000143774922026051/0001437749-22-026051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583648/000143774922026051/pirs20221103_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-026051
- JSON: https://secwatch.observer/filing/0001437749-22-026051.json
- Plain text: https://secwatch.observer/filing/0001437749-22-026051.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.